Literature DB >> 2898739

Regional distribution of immunoreactive dynorphin A in the human gastrointestinal tract.

S Spampinato1, G L Ferri, S Candeletti, P Romualdi, E Cavicchini, L Soimero, G Labò, S Ferri.   

Abstract

Immunoreactive dynorphin A (ir-Dyn A) was detected throughout the human gastrointestinal tract by a validated radioimmunoassay. Moreover, the stability of 125I-Dyn A during extraction procedures was confirmed by high performance liquid chromatography. Levels of ir-Dyn A were higher in the stomach and in the small bowel. In tissue samples separated into the main layers composing the gut wall (muscularis externa, submucosa and mucosa) ir-Dyn A was uniformly distributed. An exception was the colon, where concentrations were higher in the muscular portion. Gel permeation chromatography on samples of mucosa and muscularis externa extracts of ileum and gastric fundus, showed immunoreactive material eluting in several forms of apparently higher molecular weight than Dyn A, while only a minor peak was found to coelute with authentic Dyn A.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898739     DOI: 10.1016/0143-4179(88)90077-7

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  4 in total

1.  Effect of opioid peptides on circular muscle of canine duodenum.

Authors:  A J Bauer; J H Szurszewski
Journal:  J Physiol       Date:  1991-03       Impact factor: 5.182

2.  Regional quantitation of preprodynorphin mRNA in guinea pig gastrointestinal tract.

Authors:  V P Yuferov; J A Culpepper-Morgan; K S LaForge; A Ho; M J Kreek
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

Review 3.  Biological redundancy of endogenous GPCR ligands in the gut and the potential for endogenous functional selectivity.

Authors:  Georgina L Thompson; Meritxell Canals; Daniel P Poole
Journal:  Front Pharmacol       Date:  2014-11-28       Impact factor: 5.810

4.  Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness.

Authors:  Alexander Zaborin; Daniel Smith; Kevin Garfield; John Quensen; Baddr Shakhsheer; Matthew Kade; Matthew Tirrell; James Tiedje; Jack A Gilbert; Olga Zaborina; John C Alverdy
Journal:  mBio       Date:  2014-09-23       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.